Skip to content
Riskpilot
← Back to search
Sign in
Get full access
JANSSONS IMMUNBIOLOGISKA AKTIEBOLAG JIBA
AB
Active
Advertising protection
Org 5562547124
Lambs Väg 2, 457 95
Grebbestad
Physiotherapy activities
· NACE 8695
Est. 1985 · 41 years old
2 employees
Monitor
Share
Sweden
/
Companies
/
Physiotherapy activities
/
JANSSONS IMMUNBIOLOGISKA AKTIEBOLAG JIBA
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
2M
4M
6M
8M
7M
2020
7M
2021
6M
2022
6M
2023
6M
2024
EBITDA
SEK millions
4M
3M
2M
1M
0M
3M
2020
2M
-33%
2021
1M
-50%
2022
1M
0%
2023
1M
0%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
7 111
6 550
6 180
6 230
5 886
Staff expenses
—
—
—
—
—
EBITDA
2 545
2 067
1 205
1 195
948
Depreciation & amort.
−12
−5
−0
−0
−3
EBIT
2 533
2 062
1 205
1 195
945
Net financials
132
−7
−7
1
52
Profit before tax
2 485
2 055
1 199
1 196
997
Tax
−370
−425
−259
−262
−209
Net profit
2 115
1 630
940
934
788
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
3 091
2 580
3 292
3 283
3 150
Equity
2 237
1 750
2 690
2 724
2 512
Long-term debt
123
6
0
0
0
Short-term debt
732
824
602
559
638
Total debt
855
830
602
559
638
Financial ratios
5-year trend
EBITDA margin
16.1%
This company
15.8%
Market median
+2% vs market
2020
2024
Equity ratio
79.7%
This company
38.2%
Market median
+109% vs market
2020
2024
Return on equity
31.4%
This company
18.4%
Market median
+71% vs market
2020
2024
Net profit margin
13.4%
This company
8.1%
Market median
+65% vs market
2020
2024
Asset turnover
1.87×
This company
1.12×
Market median
+67% vs market
2020
2024
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on JANSSONS IMMUNBIOLOGISKA AKTIEBOLAG JIBA
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
